Arunjyothi Bio Ventures Limited (BOM:530881)
5.15
0.00 (0.00%)
At close: Aug 14, 2026
Arunjyothi Bio Ventures Revenue
Arunjyothi Bio Ventures had revenue of 82.00M INR in the quarter ending June 30, 2026, a decrease of -5.88%. This brings the company's revenue in the last twelve months to 272.42M, up 2.81% year-over-year. In the fiscal year ending March 31, 2026, Arunjyothi Bio Ventures had annual revenue of 277.54M, down -0.47%.
Revenue (ttm)
272.42M
Revenue Growth
+2.81%
P/S Ratio
3.52
Revenue / Employee
1.62M
Employees
168
Market Cap
959.86M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 277.54M | -1.30M | -0.47% |
| Mar 31, 2025 | 278.84M | 74.53M | 36.48% |
| Mar 31, 2024 | 204.32M | 186.96M | 1,077.40% |
| Mar 31, 2023 | 17.35M | -12.36M | -41.59% |
| Mar 31, 2022 | 29.71M | -25.42M | -46.11% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Optimus Finance | 2.01B |
| AG Ventures | 1.35B |
| Upsurge Investment & Finance | 654.85M |
| Consecutive Commodities | 614.47M |
| HB Portfolio | 298.78M |
| Apollo Finvest (India) | 202.94M |
| Bampsl Securities | 201.81M |
| Saumya Consultants | 188.88M |